Delivery Order SPE2DB20D3104-SPE2DB23FV8C2

Award Date 7/27/23
Potential Completion Date 7/28/23
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA). The $24,489.62 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 11, 2023. The order has an ultimate completion date of August 14, 2023 and is not designated as a set-aside contract. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,726.35 and a completion date of April 23, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA). The $11,483.15 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 25, 2022 with a completion date of March 28, 2022. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order with a firm fixed price. The award has a ceiling value of $8,291.85 and is set to expire on January 12, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $21,044.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, on May 9, 2025, with a completion date of May 12, 2025. The contract is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Nurtec ODT 75 mg tablets to the federal government. The $5,114.89 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 25, 2023, with a completion date of April 26, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,166.51, is a delivery order with a firm fixed price and a completion date of July 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price of $59,603.96 and an Ultimate Completion Date of April 16, 2024. It is not designated as a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Nurtec ODT 75 mg tablets. This $24,932.52 contract has an ultimate completion date of April 12, 2024 and is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products...
This federal contract award is for the delivery of Nurtec ODT 75 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $5,434.52. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 22, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV8C2
    Delivery Order

This federal contract award is for the delivery of Nurtec ODT 75 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,578.99 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 27, 2023, with a completion date of July 28, 2023.

The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 2/27/25, 11:10 AM